250
Participants
Start Date
April 30, 2006
Study Completion Date
May 31, 2007
AQUAVAN® (fospropofol disodium) Injection
United Health Scrvices Hosptial, INC, Johnson City
Pulmonary Associates of Fredericksburg, Inc., Fredericksburg
Johnston Memorial Hospital Pulmonary Research, Abingdon
ALL-TRIALS Clinical Research, LLC, Winston-Salem
Brody School of Medicine, Greenville
South Carolina Pharmaceutical Research, Spartanburg
Spartanburg Medical Research, Spartanburg
Lowcountry Lung & Critical Care, PA, Charleston
Medical University of South Carolina, Charleston
Greenville Hospital System, Greenville
Acute Care Consultants Inc., Augusta
Pensacola Research Consultants, Inc., Pensacola
Pulmonary Associates of Mobile, PC, Mobile
Graves-Gilbert Clinic, Bowling Green
University of Cincinnati, The University Hospital, Cincinnati
Hurley Medical Center, Flint
Keith Popovich, MD, PLLC, Butte
International Heart Institue of MT Foundation, Missoula
University of Nebraska Medical Center, Omaha
The University of Texas Medical Branch Division of APICS, Galveston
Precision Trials, Phoenix
USC Health Science Campus (USC University Hospital), Los Angeles
Saddleback Memorial Medical Center, Laguna Hills
Central Maine Pulmonary Associates, Auburn
Berkshire Medical Center, Pittsfield
Eisai Inc.
INDUSTRY